Nonsmall Cell Lung Carcinoma with Giant Cell Features Expressing Programmed Death-Ligand 1: A Report of a Patient Successfully Treated with Pembrolizumab

Giant cell carcinoma, a rare variant of nonsmall cell lung carcinoma (NSCLC), is characterized by aggressive progression and poor response to conventional chemotherapy. This report is the first to describe a patient with NSCLC and giant cell features who was successfully treated with pembrolizumab,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Shingo, Sasaki, Mamoru, Morinaga, Shojiroh, Minematsu, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875061/
https://www.ncbi.nlm.nih.gov/pubmed/29736285
http://dx.doi.org/10.1155/2018/5863015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875061/
https://www.ncbi.nlm.nih.gov/pubmed/29736285
http://dx.doi.org/10.1155/2018/5863015

Ejemplares similares